# Hers Health, Inc. Reports Second Quarter 2026 Financial Results

> **Open Intelligence Dossier** · First detected: 2026-08-10 21:07 UTC · Category: Business

## Executive Summary
Hims & Hers Health shares fall despite a raised revenue forecast as a larger-than-expected quarterly loss dominates financial coverage.

## Intelligence Brief
Recent financial reporting from outlets including Reuters, Barrons.com, Investor's Business Daily, TradingView, the Wall Street Journal, Yahoo Finance, and official investor relations channels details the second quarter 2026 financial results for Hims & Hers Health, Inc., traded on the New York Stock Exchange under the ticker symbol HIMS. According to the coverage, the company reported second-quarter results that included a swing to a quarterly loss alongside a bigger-than-expected loss figure that surprised financial observers. At the same time, the company boosted its full-year revenue target and raised its forward revenue forecast for the period. Despite the upward revision to the company revenue target, financial coverage heavily emphasizes the immediate negative market reaction to the larger-than-expected second-quarter loss.


Reports from Barrons.com and Investor's Business Daily note that Hims stock fell and tumbled following the earnings release, as market participants weighed the heavier-than-anticipated losses more heavily than the improved guidance. Reuters and the Wall Street Journal highlight that the stronger-than-expected quarterly loss completely overshadowed the positive news regarding the revenue forecast raise, leaving the stock price under considerable downward pressure immediately after the announcement. Context provided across the reporting indicates that market attention had been closely focused on the company performance metrics heading into the second-quarter report. TradingView articles published ahead of and alongside the results outlined what market participants needed to look for regarding the company trajectory on the New York Stock Exchange.


The juxtaposition between exceeding certain baseline expectations and posting a surprisingly stout financial loss created a complex narrative for investors assessing the underlying health of the business operations during the second quarter of the calendar year 2026. As the market digests the newly released financial data and the revised revenue targets, coverage does not yet specify exact operational drivers behind the unexpected loss or outline precise remediation steps from management. Observers will be watching to see how the company balances its aggressive revenue growth strategies against the profitability pressures that resulted in the second-quarter loss. Future reports from corporate investor relations and financial media outlets will likely track whether the increased revenue guidance translates into bottom-line improvements in subsequent quarters.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Yahoo Finance | HIMS Falls 6% After Hours On Q2 Loss— Eyes Oral Testosterone And Peptides Expansion | [Source Link](https://news.google.com/rss/articles/CBMiigFBVV95cUxNT3ZqLTNlWHYwZmt3MHd6aURVWU8zbDhuMTlUTVpZckRyeEozc24wdkk0LVBsS3ZXcEpqNVVraENodlROOExEdVhlUmZpZmJTN2hnTWw3Wkx5WV9FNU91TUFRNDVCR0dLbFRyMWZnczE2OGZ0ZEZwTVBNS1JSZks0Z0YzVU15U2QwNEE?oc=5) |
| Reuters | Hims & Hers bigger-than-expected quarterly loss overshadows revenue forecast raise | [Source Link](https://news.google.com/rss/articles/CBMiugFBVV95cUxNZE9uc3FFWEtxcEs0azRvZmRNSmctTXVZb0dGMFBvN25Oc1ExVWE4cWxPWWFNdGczX1V6dDFjS0JMSksyUXJ2NW4zRmhWck5ubWwxNEtyUi0xc2R0MGpCMjVTeHRXMHRfZC1TVFhYQzBPYVc0a0FGdkxQVm8tMVBwMHJqS0JGRGdtbWR1dTFVd1YxSWdvdUNkdjhoYlZrYUpweUsyekRNVDNBREdybXlobVY1OWFKM0pTTXc?oc=5) |
| barrons.com | Hims Stock Falls on Earnings. Why a Guidance Hike Isn’t Enough. | [Source Link](https://news.google.com/rss/articles/CBMihgFBVV95cUxPMTVZY1hpeVlyenE4ODJYYUlUMDlteTdmandiQTViTzRCWkRxeUJxWEV6d1NNQXRPaXg0VEl3UlFqRG1xMVl5X3dNTGFIdG1ucjJrZmhpNDRscmF4VU1LcU9Ddkx2OGE2OFZhZkRadDZSaTE5ZmUxTzJKMUZ0R3R1a1hVWHAwUQ?oc=5) |
| Investor's Business Daily | Hims Tumbles On Surprisingly Stout Losses | [Source Link](https://news.google.com/rss/articles/CBMikAFBVV95cUxObTdZWUxkeTFHQWI0TVpGcTNyME02VUpQeUZFTmhpYXoxZmQxVVBkamoxeXl1cUNIWlFFZVlmM2haX3o1bjEtNlk1MlNTUzYzV3J3U2FON3VUSjRwQmJ3X0hlUmlVZ0V3NThsMGpVSEJNSlJOZjdJSFprQTBYWnpCRk5wdWUtSVRCV2pPSkM3bFI?oc=5) |
| TradingView | Hims & Hers Health Earnings: What To Look For From HIMS | [Source Link](https://news.google.com/rss/articles/CBMiswFBVV95cUxQU3d2QVN4MExLQmlhMjlEYlg3T0FTcGZyTGstbjJMVGJ0ZEJVb1RMM0tfc0pFN0N4YVdQdEYzOVhwSHdDZXA4VS1kOU8tYW5ZZS1qMnp6WUNEeFVFdm0xMW8xMHhpZG9UQUlqeHpEdlFMSVlDc1lpMFRMd3FaajhzV1NoeDh5N3NSYXBvWTFZVnFsaC01RnE5RjUtdi1MdE82cDZKV09zRmpCenc1eWhiZWNuRQ?oc=5) |
| WSJ | Hims & Hers Health Boosts Revenue Target, Swings to Second-Quarter Loss | [Source Link](https://news.google.com/rss/articles/CBMitgFBVV95cUxNRmlfQjk5eElsNzhjQm1hZUhwVkEtNGpyT3RXOFdEV0R3aDlSSVhENjNaQVJUWWdmQ3d5VUNHZDRLUHpic3R2ZUtON1pmM21TU0hlTHdJQVJ5UVpEc0ZtSlg4MmcxOHZRYUYtWlcxbUNETzhFa3ExWnMxNHNpMVlrZ2YxMEVTa3lONkwtQVBjQjZhb3dOU3U5ZDZFZXFyYmYyaW44Y3AxQXFFYzM1Qi1qRUR6Qkw5QQ?oc=5) |
| Yahoo Finance | Hims & Hers Health (NYSE:HIMS) Exceeds Q2 CY2026 Expectations But Stock Drops | [Source Link](https://news.google.com/rss/articles/CBMikAFBVV95cUxOWW5EbzJFQ2RLRzZBZVJTeElJM1REczVYSmpYbDhJNWViV3dscEJEMFVKQlhoclg3TjZhSWxhTzdPMS03OFFhaTJEb2FXZEVmTHZSeXY3WFhPanpJbTg2LUQ2MVRLN3dyVFRKeGxqem9nM09ING1aOG5CMV9ESDNUeXFWck52QV9sOS1HTGdOcFk?oc=5) |
| HIMS investor relations | Hers Health, Inc. Reports Second Quarter 2026 Financial Results | [Source Link](https://news.google.com/rss/articles/CBMiywFBVV95cUxNUlRKdDYtN2JfZUFPa0gtN1B6Sm1oeWNFNFZDOFlyQk1jZFBIZjlsblNuX0Rkb0JybFVfZUxlOVJ0NkNFd0xjUGczU1NSTExwSmN6aHVsTUhNRi1nVkVOR1U3bTF5NGVpTWk3Slc5dWFHUmtmRDZVSUJQSTZoQUFfelh0OFBFV2ZMU0gyX0FUMTJrN0pWVjlrR1pELWJZT0RMNGFrV1FPN1puTU9GTlhxQjk4Q1VfMlQyNThFRk55dmFYdllvWC1OelRINA?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-08-10/hers-health-inc-reports-second-quarter-2026-financial-results*